The eSMART study protocol: a randomised controlled trial to evaluate electronic symptom management using the advanced symptom management system (ASyMS) remote technology for patients with cancer
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Introduction: While some evidence exists that real-time remote symptom monitoring devices can decrease morbidity and prevent unplanned admissions in oncology patients, overall, these studies have significant methodological weaknesses. The electronic Symptom Management using the Advanced Symptom Management System (ASyMS) Remote Technology (eSMART) study is designed to specifically address these weaknesses with an appropriately powered, repeated-measures, parallel-group stratified randomised controlled trial of oncology patients. Methods and analysis: A total of 1108 patients scheduled to commence first-line chemotherapy (CTX) for breast, colorectal or haematological cancer will be recruited from multiple sites across five European countries. Patients will be randomised (1:1) to the ASyMS intervention (intervention group) or to standard care currently available at each site (control group). Patients in the control and intervention groups will complete a demographic and clinical questionnaire, as well as a set of valid and reliable electronic patient-reported outcome measures at enrolment, after each of their CTX cycles (up to a maximum of six cycles) and at 3, 6, 9 and 12 months after completion of their sixth cycle of CTX. Outcomes that will be assessed include symptom burden (primary outcome), quality of life, supportive care needs, anxiety, self-care self-efficacy, work limitations and cost effectiveness and, from a health professional perspective, changes in clinical practice (secondary outcomes). Ethics and dissemination: Ethical approval will be obtained prior to the implementation of all major study amendments. Applications will be submitted to all of the ethics committees that granted initial approval. eSMART received approval from the relevant ethics committees at all of the clinical sites across the five participating countries. In collaboration with the European Cancer Patient Coalition (ECPC), the trial results will be disseminated through publications in scientific journals, presentations at international conferences, and postings on the eSMART website and other relevant clinician and consumer websites; establishment of an eSMART website (www.esmartproject.eu) with publicly accessible general information; creation of an eSMART Twitter Handle, and production of a toolkit for implementing/utilising the ASyMS technology in a variety of clinical practices and other transferable health care contexts. Trial registration number: NCT02356081.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The functional assessment of cancer therapy scale: development and validation of the general measure
Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., Silberman, M., Yellen, S. B., Winicour, P., & Brannon, J. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.570 · Cited by 6,020
State-Trait Anxiety Inventory for Adults
Spielberger, C. D. (2012) · PsycTESTS Dataset · doi:10.1037/t06496-000 · Cited by 3,479
Basch, E., Deal, A. M., Kris, M. G., Scher, H. I., Hudis, C. A., Sabbatini, P., Rogak, L., Bennett, A. V., Dueck, A. C., Atkinson, T. M., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.0830 · Cited by 2,593
Self-management: Enabling and empowering patients living with cancer as a chronic illness
McCorkle, R., Ercolano, E., Lazenby, M., Schulman-Green, D., Schilling, L. S., Lorig, K., & Wagner, E. H. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20093 · Cited by 950
Frison, L., & Pocock, S. J. (1992) · Statistics in Medicine · doi:10.1002/sim.4780111304 · Cited by 593
Boyes, A., Girgis, A., & Lecathelinais, C. (2009) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2008.01057.x · Cited by 530
Kearney, N., McCann, L., Norrie, J., Taylor, L., Gray, P., McGee-Lennon, M., Sage, M., Miller, M., & Maguire, R. (2009) · Supportive Care in Cancer · doi:10.1007/s00520-008-0515-0 · Cited by 263
Self-citationNew MRC guidance on evaluating complex interventions
Anderson, R. (2008) · BMJ · doi:10.1136/bmj.a1937 · Cited by 172
Do health improvement programmes fit with MRC guidance on evaluating complex interventions?
Mackenzie, M., O'Donnell, C., Halliday, E., Sridharan, S., & Platt, S. (2010) · BMJ · doi:10.1136/bmj.c185 · Cited by 127
Spichiger, E., Rieder, E., Müller-Fröhlich, C., & Kesselring, A. (2012) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2011.05.002 · Cited by 63
Research works printed but not linked: 45
- 10.1080/02841860151116349 · DOI · Paper page
- 10.1001/archinternmed.2007.125 · doi:10.1001/archinternmed.2007.125
- 10.1038/bjc.2012.228 · doi:10.1038/bjc.2012.228
- 10.1200/JCO.2013.49.4757 · DOI · Paper page
- 10.1007/s00520-004-0710-6 · DOI · Paper page
- 10.1089/jayao.2014.0023 · DOI · Paper page
- 10.1002/cncr.21847 · DOI · Paper page
- 10.1007/s00520-014-2553-0 · doi:10.1007/s00520-014-2553-0
- Chindaprasirt, 2013, Mortality, length of stay, and cost associated with hospitalized adult Cancer patients with febrile neutropenia, Asian Pac J Cancer Prev, 14, 1115, 10.7314/APJCP.2013.14.2.1115 · doi:10.7314/apjcp.2013.14.2.1115
- 10.1177/1078155211436022 · DOI
- 10.1093/annonc/mdq759 · DOI
- 10.1007/s00520-010-0913-y · DOI
- 10.1188/07.ONF.1162-1167 · doi:10.1188/07.onf.1162-1167
- 10.1007/s00520-012-1448-1 · DOI · Paper page
- 10.1007/s00520-010-1073-9 · doi:10.1007/s00520-010-1073-9
- Husson, 2015, Variation in fatigue among 6011 (long-term) cancer survivors and a normative population: a study from the population-based PROFILES registry, Support Care Cancer, 23, 2165, 10.1007/s00520-014-2577-5 · DOI
- 10.1188/12.ONF.E31-E40 · DOI
- 10.1016/S0020-7489(00)00106-1 · DOI
- 10.1186/1477-7525-8-65 · DOI
- Coolbrandt, 2011, Immediate versus delayed self-reporting of symptoms and side effects during chemotherapy: does timing matter?, Eur J Oncol Nurs, 15, 130, 10.1016/j.ejon.2010.06.010 · DOI
- 10.1016/j.ejon.2011.02.005 · DOI
- Kotronoulas, 2012, Informal carers: a focus on the real caregivers of people with Cancer, Forum Clin Oncol, 3, 58
- Butow, 2012, Psychosocial well-being and supportive care needs of Cancer patients living in urban and rural/regional areas: a systematic review, Support Care Cancer, 20, 1, 10.1007/s00520-011-1270-1 · DOI · Paper page
- 10.1097/PPO.0b013e31822c28b3 · DOI · Paper page
- 10.1188/08/ONF.661-669 · DOI
- 10.1200/JOP.2013.001067 · DOI · Paper page
- 10.1016/j.ejon.2009.03.004 · DOI
- 10.1097/NCC.0b013e3181cb4bad · DOI
- 10.1007/s00520-005-0002-9 · DOI
- 10.1177/1744987108099235 · DOI
- 10.1016/j.ejon.2008.04.007 · DOI
- Maguire, 2005, Results of a UK based pilot study of a mobile phone based advanced symptom management system (ASyMS) in the remote monitoring of chemotherapy related toxicity, Clin Eff Nurs, 9, 202, 10.1016/j.cein.2006.08.013 · DOI
- 10.12968/ijpn.2008.14.9.31121 · DOI · Paper page
- 10.1007/s11136-008-9396-4 · DOI · Paper page
- 10.1007/s11136-008-9414-6 · DOI
- 10.3322/caac.21150 · DOI · Paper page
- Vickers, 2011, Prediction models in Cancer care, CA Cancer J Clin, 61, n/a, 10.3322/caac.20118 · DOI · Paper page
- Kofoed, 2012, Benefits of remote real-time side-effect monitoring systems for patients receiving Cancer treatment, Oncol Rev, 6, 7, 10.4081/oncol.2012.e7 · DOI
- 10.1016/0959-8049(94)90182-1 · DOI · Paper page
- 10.1016/j.pec.2004.09.005 · DOI
- 10.1016/S0895-4356(01)00424-3 · DOI · Paper page
- McCann, 2009, Patients' perceptions and experiences of using a mobile phone-based advanced symptom management system (ASyMS) to monitor and manage chemotherapy related toxicity, Eur J Cancer Care, 18, 156, 10.1111/j.1365-2354.2008.00938.x · DOI · Paper page
- 10.1016/j.ijnurstu.2012.09.009 · DOI · Paper page
- 10.1186/1472-6963-10-180 · DOI
- 10.1097/NCC.0b013e31824d90d4 · DOI · Paper page
Cited by
What is the clinical value of mHealth for patients?
Rowland, S. P., Fitzgerald, J. E., Holme, T., Powell, J., & McGregor, A. (2020) · npj Digital Medicine · doi:10.1038/s41746-019-0206-x · Cited by 454
Phase III Randomized Controlled Trial of eRAPID: eHealth Intervention During Chemotherapy
Absolom, K., Warrington, L., Hudson, E., Hewison, J., Morris, C., Holch, P., Carter, R., Gibson, A., Holmes, M., Clayton, B., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.02015 · Cited by 311
Digital health for optimal supportive care in oncology: benefits, limits, and future perspectives
Aapro, M., Bossi, P., Dasari, A., Fallowfield, L., Gascón, P., Geller, M., Jordan, K., Kim, J., Martin, K., & Porzig, S. (2020) · Supportive Care in Cancer · doi:10.1007/s00520-020-05539-1 · Cited by 311
Maguire, R., McCann, L., Kotronoulas, G., Kearney, N., Ream, E., Armes, J., Patiraki, E., Furlong, E., Fox, P., Gaiger, A., et al. (2021) · BMJ · doi:10.1136/bmj.n1647 · Cited by 243
Self-citationRincon, E., Monteiro-Guerra, F., Rivera-Romero, O., Dorronzoro-Zubiete, E., Sanchez-Bocanegra, C. L., & Gabarron, E. (2017) · JMIR mHealth and uHealth · doi:10.2196/mhealth.8741 · Cited by 108
Metadata
- Authors
- Maguire, R., Fox, P. A., McCann, L., Miaskowski, C., Kotronoulas, G., Miller, M., Furlong, E., Ream, E., Armes, J., Patiraki, E., Gaiger, A., Berg, G. V., Flowerday, A., Donnan, P., McCrone, P., Apostolidis, K., Harris, J., Katsaragakis, S., Buick, A. R., & Kearney, N.
- Venue
- BMJ Open
- Publisher
- BMJ
- Published
- 2017-05
- Volume
- 7
- Issue
- 5
- Pages
- e015016
- ISSN
- 2044-6055 (ISSN-L)
- OpenAlex
- W2604093837
- Cited by
- 172
- References
- 10
- FWCI
- 10.34
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- Seventh Framework Programme
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.